Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Asylum Research Licenses Magnetic Actuated Cantilever Technology

Asylum Research Licenses Magnetic Actuated Cantilever Technology

Santa Barbara, CA | Posted on November 04, 2005

Asylum Research, a leading manufacturer of atomic force microscopes (AFMs), announced an exclusive licensing agreement with the Institut Curie of Paris for their Atomic Force Microscope patent on magnetic actuated cantilever technology. The license agreement covers use in US and European markets.

The cantilevers are actuated by driving a tiny oscillating current through the legs of the cantilever. In a magnetic field, even one as small as the earth's, this oscillating current results in an actuation force, directly driving the cantilever. "This licensing agreement will add another powerful capability for imaging samples with our MFP-3D™ instruments, particularly in fluid, " said Dr. Roger Proksch, president of Asylum Research. "This new technology overcomes serious limitations of other magnetically actuated techniques that require magnetic coated cantilevers. The quality of the magnetic film coating is unreliable and may corrupt an experiment with unwanted metal (Fe, Ni or Co) ions."

Magnetically actuated cantilever technology allows non-destructive atomic force microscopy of sensitive samples, particularly for imaging bioscience and polymer samples in fluid.

MFP-3D is a trademark of Asylum Research

####

About Asylum Research:
Asylum Research manufactures advanced scientific instrumentation, including AFMs/ Scanning Probe Microscopes (SPMs), for nanoscale science and technology. An AFM/SPM is one of the premier instruments used for measuring surfaces and surface properties at the nanometer level.

For more information, please click here

About Institut Curie:
The Institut Curie is a private foundation headquartered in Paris, France, and is focused on fighting cancer. In addition to their research activities, they are also a hospital.

For more information, please click here

Contact:
Terry Mehr
Director of Marketing
805-696-6466
terry@asylumresearch.com

Copyright © Asylum Research

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Announcements

Imaging electric charge propagating along microbial nanowires October 20th, 2014

Design of micro and nanoparticles to improve treatments for Alzheimers and Parkinsons: At the Faculty of Pharmacy of the UPV/EHU-University of the Basque Country encapsulation techniques are being developed to deliver correctly and effectively certain drugs October 20th, 2014

Physicists build reversible laser tractor beam October 20th, 2014

Removal of Limitations of Composites at Superheat Temperatures October 20th, 2014

Tools

New Grand ARM Transmission Electron Microscope Offers Highest Commercially-Available Atomic Resolution of 63 Picometers October 17th, 2014

Nanodevices for clinical diagnostic with potential for the international market: The development is based on optical principles and provides precision and allows saving vital time for the patient October 15th, 2014

Nanotronics Imaging Releases nSPEC® 3D, Powerful Microscope That Captures 3D Images at Nanoscale, in Lightning Speed: Company Unveils Design at American Chemical Society 2014 International Elastomer Conference October 14th, 2014

Unique catalysts for hydrogen fuel cells synthesized in ordinary kitchen microwave oven October 14th, 2014

Patents/IP/Tech Transfer/Licensing

Nanodevices for clinical diagnostic with potential for the international market: The development is based on optical principles and provides precision and allows saving vital time for the patient October 15th, 2014

Aculon Receives Patent for Application of Enhanced Bonding Layers on Titanium October 9th, 2014

harmaEngine will join Nanobiotix’ pivotal trial for NBTXR3 in Soft Tissue Sarcoma to accelerate its development in Asia-Pacific: PharmaEngine to make milestone payment to Nanobiotix in October 2014 to recognize the value created October 8th, 2014

‘Small’ transformation yields big changes September 16th, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE